Successful Treatment of Long-Term, Poststroke, Upper-Limb Spasticity With OnabotulinumtoxinA

被引:19
作者
Patel, Atul T. [1 ,2 ]
机构
[1] Kansas City Bone & Joint Clin, PA, Overland Pk, KS 66211 USA
[2] Rehabil Inst Kansas City, Kansas City, MO USA
来源
PHYSICAL THERAPY | 2011年 / 91卷 / 11期
关键词
TOXIN TYPE-A; BOTULINUM TOXIN; STROKE; REHABILITATION; ASSOCIATION; PREVALENCE; MANAGEMENT; CARE;
D O I
10.2522/ptj.20100370
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Background and Purpose. Poststroke spasticity often negatively affects functional activities and daily living and frequently is accompanied by pain, abnormal limb postures, and contractures. The purpose of this case report is to describe the long-term benefit of botulinum toxin A in a patient with poststroke spasticity. Case Description. A 35-year-old woman with poststroke upper-limb spasticity who had lost function in her left hand was treated with onabotulinumtoxinA and physical therapy. Over 25 months, the patient received a physical therapy and occupational therapy program and received onabotulinumtoxinA injections into muscles of the left hand and arm, significantly reducing tone and facilitating recovery of function. Practical assessments, the Ashworth Scale, and electrophysiology were used to measure changes over time. No functional scales or dexterity scales were used to measure changes. Outcomes. OnabotulinumtoxinA injections were discontinued when treatment goals were attained, and no further improvements were achieved. After more than 21/2 years without further onabotulinumtoxinA treatments, the patient maintained range of motion and some functional use and dexterity in her left hand. Discussion. This case report illustrates the efficacy and long-term benefit of onabotulinumtoxinA, combined with physical therapy and occupational therapy, in the successful treatment of poststroke spasticity.
引用
收藏
页码:1636 / 1641
页数:6
相关论文
共 28 条
[1]
ASHWORTH B, 1964, PRACTITIONER, V192, P540
[2]
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke [J].
Brashear, A ;
Gordon, MF ;
Elovic, E ;
Kassicieh, VD ;
Marciniak, C ;
Lee, CH ;
Jenkins, S ;
Turkel, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :395-400
[3]
Spasticity [J].
Brashear, Allison ;
Lambeth, Kelly .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (03) :153-161
[4]
Optimizing stroke systems of care by enhancing transitions across care environments [J].
Cameron, Jill I. ;
Tsoi, Chris ;
Marsella, Amanda .
STROKE, 2008, 39 (09) :2637-2643
[5]
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke [J].
Childers, MK ;
Brashear, A ;
Jozefczyk, P ;
Reding, M ;
Alexander, D ;
Good, D ;
Walcott, JM ;
Jenkins, SW ;
Turkel, C ;
Molloy, PT .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (07) :1063-1069
[6]
*CTR DIS CONTR, 2007, OUTP REH STROK SURV
[7]
Dolly O, 2003, HEADACHE, V43, pS16
[8]
Management of adult stroke rehabilitation care - A clinical practice guideline [J].
Duncan, PW ;
Zorowitz, R ;
Bates, B ;
Choi, JY ;
Glasberg, JJ ;
Graham, GD ;
Katz, RC ;
Lamberty, K ;
Reker, D .
STROKE, 2005, 36 (09) :E100-E143
[9]
Health status of individuals with mild stroke [J].
Duncan, PW ;
Samsa, GP ;
Weinberger, M ;
Goldstein, LB ;
Bonito, A ;
Witter, DM ;
Enarson, C ;
Matchar, D .
STROKE, 1997, 28 (04) :740-745
[10]
Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients [J].
Elovic, Elie P. ;
Brashear, Allison ;
Kaelin, Darryl ;
Liu, Jingyu ;
Millis, Scott R. ;
Barron, Richard ;
Turkel, Catherine .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (05) :799-806